# Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)

> **NCT03838445** · NA · RECRUITING · sponsor: **V-Wave Ltd** · enrollment: 20 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DEVICE:** V-Wave Interatrial Shunt

## Key facts

- **NCT ID:** NCT03838445
- **Lead sponsor:** V-Wave Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-14
- **Primary completion:** 2026-06-30
- **Final completion:** 2031-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03838445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03838445, "Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03838445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*